Nuvig Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4200 Bohannon Dr Ste 250, Menlo Park, Ca...Phone Number
(858) 344-8091Website
www.nuvigtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About Nuvig Therapeutics
Nuvig Therapeutics is a clinical-stage biotechnology company that is advancing an innovative and transformational pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.Explore more
Nuvig Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvig Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nuvig Therapeutics
Nuvig Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nuvig Therapeutics is spiking on competitors!
Check if Nuvig Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nuvig Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Nuvig Therapeutics has new funding data
Product Launch: Get notified when Nuvig Therapeutics launches new products
Click to see if Nuvig Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Nuvig Therapeutics
Find 3 more new buyers
Compare Similar Companies to Nuvig Therapeutics
Compare insights from companies similar to Nuvig Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvig Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nuvig Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nuvig Therapeutics.
Nuvig Therapeutics financials insights
Gather financial insights about Nuvig Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$47M
2024
Series B
$161M
Nuvig Therapeutics Tech Stack
A closer look at the technologies used by Nuvig Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Nuvig Therapeutics News & Media
Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 Data
MENLO PARK, Calif.--(BUSINESS WIRE)-- #autoimmunediseases--Nuvig Therapeutics Announces First Patient Dosed in Phase 2 CIDP Trial of NVG-2089 and Presentation of Phase 1 DataFollow the Money: Teaching AI Physics, AI-Powered Digital Twins of Cells, More
Stay on top of emerging IT trends in biomedicine. Read the latest news on genomics, computational science, and more. Get recent updates today!Goodwin Advised Nuvig Therapeutics On $161 Million Series B Financing And Progression ...
The Life Sciences team advised Nuvig Therapeutics, Inc., (“Nuvig”) on the closing of a $161 million Series B financing co-led by Sanofi Ventures, Blue Owl Healthcare Opportunities...Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
California-based biotech Nuvig Therapeutics scooped up $161 million from the investment arms of Sanofi, Bayer, Novo Holdings, BMS and others for its Fc fragment immunomodulator aimed at improving autoimmune dysregulation.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuvig Therapeutics
Sign Up For FreeTo access detailed company insights
Nuvig Therapeutics is a clinical-stage biotechnology company that is advancing an innovative and transformational pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.... Read More
